These data also raise the prospect of potentially enhancing the generation of physiological immune responses through combination therapies with checkpoint inhibitors that could potentially unleash tumour- reactive T cells and enable antitumour immunity beyond the specificity determined by the CAR.
doxycycline Studies focusing on patients with MDR Gram- negative bacterial infections were considered eligible for the meta- analysis, if such studies had reported available data of clinical response, microbiological response, adverse events, or mortality for the treatment of DCT.
